Sg Americas Securities, LLC Immunovant, Inc. Transaction History

Sg Americas Securities, LLC

$27.6 Billion
Q3 2024

A detailed history of Sg Americas Securities, LLC transactions in Immunovant, Inc. stock. As of the latest transaction made, Sg Americas Securities, LLC holds 15,944 shares of IMVT stock, worth $438,619. This represents 0.0% of its overall portfolio holdings.

Number of Shares

15,944

Previous 30,702 48.07%

Holding current value

$438,619

Previous $811,000 43.9%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 03, 2024	SELL	$27.51 - $27.51 $405,992 - $405,992	-14,758 Reduced 48.07%	15,944 $455,000
Q2 2024 Jul 12, 2024	BUY	$25.1 - $31.61 $666,304 - $839,119	26,546 Added 638.74%	30,702 $811,000
Q1 2024 May 06, 2024	SELL	$30.27 - $43.79 $780,390 - $1.13 Million	-25,781 Reduced 86.12%	4,156 $134,000
Q4 2023 Jan 12, 2024	SELL	$31.31 - $44.19 $2.09 Million - $2.95 Million	-66,766 Reduced 69.04%	29,937 $1.26 Million
Q3 2023 Oct 13, 2023	BUY	$18.55 - $39.96 $942,247 - $2.03 Million	50,795 Added 110.65%	96,703 $3.71 Million
Q2 2023 Jul 10, 2023	BUY	$14.2 - $23.75 $187,553 - $313,690	13,208 Added 40.39%	45,908 $871,000
Q1 2023 Apr 28, 2023	BUY	$15.27 - $19.72 $178,246 - $230,191	11,673 Added 55.51%	32,700 $507,000
Q4 2022 Feb 02, 2023	BUY	$6.59 - $17.75 $28,488 - $76,733	4,323 Added 25.88%	21,027 $373,000
Q3 2022 Oct 31, 2022	SELL	$3.93 - $6.37 $23,257 - $37,697	-5,918 Reduced 26.16%	16,704 $93,000
Q2 2022 Jul 29, 2022	BUY	$3.38 - $5.65 $76,462 - $127,814	22,622 New	22,622 $88,000
Q1 2022 Apr 29, 2022	SELL	$5.06 - $8.77 $76,061 - $131,830	-15,032 Closed	0 $0
Q4 2021 Feb 07, 2022	SELL	$7.33 - $9.32 $93,215 - $118,522	-12,717 Reduced 45.83%	15,032 $128,000
Q3 2021 Nov 01, 2021	BUY	$7.01 - $11.37 $194,520 - $315,506	27,749 New	27,749 $241,000
Q2 2021 Aug 12, 2021	SELL	$9.4 - $16.85 $850,502 - $1.52 Million	-90,479 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$13.08 - $49.6 $1.13 Million - $4.27 Million	86,126 Added 1978.54%	90,479 $1.45 Million
Q4 2020 Feb 04, 2021	SELL	$36.36 - $52.71 $97,772 - $141,737	-2,689 Reduced 38.19%	4,353 $201,000
Q3 2020 Nov 09, 2020	SELL	$22.61 - $38.9 $76,399 - $131,443	-3,379 Reduced 32.42%	7,042 $248,000
Q2 2020 Jul 20, 2020	BUY	$13.87 - $28.44 $144,539 - $296,373	10,421 New	10,421 $254,000

Others Institutions Holding IMVT

# of Institutions

212

Shares Held

66.9M

Call Options Held

2.3M

Put Options Held

631K

View Full List

About Immunovant, Inc.

Ticker IMVT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 129,077,000
Market Cap $3.55B
Description
Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops batoclimab, a novel fully human monoclonal antibody that selectively binds to and inhibits the neonatal fragment crystallizable receptor, which is in Phase IIa clinical trials for the treatment of mya...

More about IMVT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.

Account

Sg Americas Securities, LLC Immunovant, Inc. Transaction History